Florida bans deadly 7-OH chemical after hundreds of overdose deaths
Florida bans deadly 7-OH chemical after hundreds of overdose deaths
Florida bans deadly 7-OH chemical after hundreds of overdose deaths
Florida has introduced an emergency rule to ban the opioid-like chemical 7-OH. The substance has been tied to hundreds of overdose deaths and poison control cases in the state. Authorities are now taking strong action to curb its spread. 7-OH is sold in gas stations and vape shops under various brand names. These include Hydroxy, 7Tabz, and 7OHMZ. The chemical has been linked to at least 587 overdose deaths in Florida since 2013.
The new rule classifies 7-OH as a Schedule I substance. This allows felony-level arrests and the closure of businesses selling it illegally. It also limits the amount of 7-OH in products to 1 milligram per gram for solids or pills, or per millilitre for liquids.
Medical experts have raised alarms about the dangers of 7-OH. Melissa Golombek, Executive Vice President of the Florida Health Sciences Center, warns that the substance is addictive and potentially lethal. Dr. Cory Howard, an emergency medicine physician, confirms that overdoses involving 7-OH have risen sharply in recent years. The chemical can cause respiratory depression, addiction, and severe withdrawal symptoms.
The Food and Drug Administration has already warned consumers to avoid 7-OH. Warning letters have been sent to companies illegally distributing products containing the substance. The emergency rule aims to reduce the harm caused by 7-OH. It enables law enforcement to take action against illegal sellers. Health officials continue to urge the public to avoid the dangerous chemical.
German nursing care reform faces delay as DAK-Gesundheit demands major revisions
A last-minute plea to halt the reform exposes deep flaws in Germany's care system. Will the government rewrite the rules—or risk financial chaos for families and towns?
Region's healthcare transformation brings new hospitals and cutting-edge upgrades
From rural clinics to urban polyclinics, this region's healthcare overhaul is setting new standards. Discover how 149 new facilities and global-trained doctors are reshaping patient care.
FDA's peptide safety review sparks conflict-of-interest concerns this July
From muscle growth to anti-aging, peptides promise miracles—but can the FDA's review be trusted with insiders profiting from the same drugs? A deep dive into the controversy.
Debt repayments now outpace healthcare spending in poorer nations
Kenya spends 29% of revenue on debt—three times its healthcare budget. The IMF's austerity push deepens inequality and strains public services.